Sign Up
HB 7156 Connecticut House · 2025 Regular Session

AN ACT CONCERNING THE DEPARTMENT OF DEVELOPMENTAL SERVICES' RECOMMENDATIONS REGARDING VARIOUS REVISIONS TO DEVELOPMENTAL SERVICES STATUTES.

HB 7156 revises Connecticut's developmental services statutes to clarify medication administration rules and update definitions of abuse and neglect. It specifically permits the use of auto-injectors for epinephrine or insulin to treat acute allergic reactions or diabetes in residential facilities, but only when administered by trained staff following physician orders. The bill also standardizes key terms like "abuse," "neglect," and "financial exploitation" to ensure consistent investigations and reporting across facilities. These changes directly affect individuals receiving developmental services in licensed facilities and the staff providing care.
Issues: ✓ HealthcareSupports HealthcareAllows trained staff to administer auto-injectors for acute allergic reactions/diabetes in residential facilities, improving immediate patient access to critical care per physician orders.95% confidence
Bill status signed all 5 stages cleared
Introduction
Mar 2025
Committee Review
Mar 2025
House Passage
May 2025
Senate Passage
Jun 2025
Signed into Law
Jun 2025
Introduced Mar 5, 2025 Signed Jun 23, 2025
Maddy AI version diff · 1 comparison

What changed between versions

Raised Bill → PH Joint Favorable Substitute · 4 edits
MODERATE
This bill changes how medications can be administered in residential facilities, expands who can file guardianship petitions for financial management, and updates definitions related to abuse and neglect in developmental services. The changes clarify that auto-injectors can only be used for specific medical emergencies like allergic reactions or diabetes in certain facilities, and add new protections for financial exploitation.
Scope change
The bill expands the scope of who can file guardianship petitions for financial management and clarifies the scope of medication administration rules in residential facilities.
REQUIREMENT

Restricts auto-injector medication administration to only epinephrine or insulin for treating acute allergic reactions or diabetes, and limits it to specific facility types.

ELIGIBILITY

Expands who can file guardianship petitions to include plenary or limited guardians, protected persons, and their legal representatives, specifically for managing finances of individuals with assets under $10,000.

DEFINITION

Adds new definitions for 'Community companion home designee', 'Financial exploitation', and reorganizes existing definitions to clarify abuse and neglect categories.

SCOPE

Expands the scope of individuals covered by medication administration rules to include those in facilities under multiple departments including Children and Families, Correction, Developmental Services, and Mental Health.

Floor votes · Senate Jun 2, 2025 · House May 22, 2025

How they voted

36–0
Passed
Total votes 36
Jun 2, 2025
D Democratic25
25 Yea
100% Yea
R Republican11
11 Yea
100% Yea
Vote distribution
All Yea All Nay Mixed No data
Full legislative history

Actions timeline

Total actions
18
Key actions
4
Committee
2
Jun 23, 2025
Signed into law
SIGNED BY GOVERNOR
lower
Jun 2, 2025
Upper · Passed
SENATE PASSED
upper
May 22, 2025
Lower · Passed
HOUSE PASSED
lower
Mar 12, 2025
Lower · Passed
Joint Favorable Substitute
lower
Mar 5, 2025
Committee
REF. TO JOINT COMM. ON Public Health
lower
0 primary · 0 co-sponsors

Sponsors

No sponsor information available.